{"title":"[抗纤维化药物作为特发性肺纤维化的新疗法]。","authors":"M. Funke-Chambour, T. Geiser","doi":"10.1024/0040-5930/a000751","DOIUrl":null,"url":null,"abstract":"Recent studies have shown efficacy to slow the decrease of forced vital capacity in patients with idiopathic pulmonary fibrosis. This summary refers to recent anti-fibrotic medications and describes current studies, indication for treatment and side effects, as well as discusses open questions of treatment.","PeriodicalId":87030,"journal":{"name":"Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale","volume":"33 1","pages":"25-9"},"PeriodicalIF":0.0000,"publicationDate":"2016-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"[Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].\",\"authors\":\"M. Funke-Chambour, T. Geiser\",\"doi\":\"10.1024/0040-5930/a000751\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Recent studies have shown efficacy to slow the decrease of forced vital capacity in patients with idiopathic pulmonary fibrosis. This summary refers to recent anti-fibrotic medications and describes current studies, indication for treatment and side effects, as well as discusses open questions of treatment.\",\"PeriodicalId\":87030,\"journal\":{\"name\":\"Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale\",\"volume\":\"33 1\",\"pages\":\"25-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1024/0040-5930/a000751\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutische Umschau und medizinische Bibliographie. Revue therapeutique et bibliographie medicale","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1024/0040-5930/a000751","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].
Recent studies have shown efficacy to slow the decrease of forced vital capacity in patients with idiopathic pulmonary fibrosis. This summary refers to recent anti-fibrotic medications and describes current studies, indication for treatment and side effects, as well as discusses open questions of treatment.